Viatris Inc recalls alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Read the official notice →- Date
- 2022-05-11
- Country
- United States
- Brand
- Viatris
- Product
- alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.
- Classification
- Class II
- Units
- Product was distributed nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Viatris recalls
- 2023-06-14
USViatris Inc recalls Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only,…
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
FDA · DrugViatris IncProduct was distributed to 10 distributors who may have further distribute the…Official notice →- 2022-11-23
- US
Viatris Inc recalls Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC…
Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
- 2022-11-16
- US
Viatris Inc recalls Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only,…
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
- 2022-10-05
- US
Viatris Inc recalls Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan…
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
- 2022-05-18
- US
Viatris Inc recalls Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer…
Failed Dissolution Specifications: low out of specification results for dissolution.
- 2021-10-06
- US
Other drugs & medical recalls in the United States
- 2022-05-11
- US
- US
McKesson Corporation dba McKesson Drug Company recalls Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent…
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
FDA · DrugMcKesson Corporation dba McKesson Drug CompanyNationwide in the United States including Guam and the Northern Mariana Islands.Official notice → - US
Akorn, Inc. recalls Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc.…
Failed viscosity specification - product was below specificcation
- US
Lupin Pharmaceuticals Inc. recalls Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-378-09), Rx Only,…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
- US
Macleods Pharma Usa Inc recalls Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count…
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
- US
SCA Pharmaceuticals recalls Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44
CGMP Deviations
FDA · DrugSCA PharmaceuticalsProduct was distributed nationwide within the United StatesOfficial notice →